120 related articles for article (PubMed ID: 17156011)
21. The MAP kinase-activated protein kinase Rck2p plays a role in rapamycin sensitivity in Saccharomyces cerevisiae and Candida albicans.
Li X; Huang X; Zhao J; Zhao J; Wei Y; Jiang L
FEMS Yeast Res; 2008 Aug; 8(5):715-24. PubMed ID: 18625027
[TBL] [Abstract][Full Text] [Related]
22. Genome-wide expression profiling of the response to terbinafine in Candida albicans using a cDNA microarray analysis.
Zeng YB; Qian YS; Ma L; Gu HN
Chin Med J (Engl); 2007 May; 120(9):807-13. PubMed ID: 17531123
[TBL] [Abstract][Full Text] [Related]
23. Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans.
Simonetti G; Passariello C; Rotili D; Mai A; Garaci E; Palamara AT
FEMS Yeast Res; 2007 Dec; 7(8):1371-80. PubMed ID: 17627775
[TBL] [Abstract][Full Text] [Related]
24. [Study on antifungal mechanism of alpha-pinene].
Xia Z; Mao X; Luo Y
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(6):507-9. PubMed ID: 12080706
[TBL] [Abstract][Full Text] [Related]
25. In vitro antifungal activity of 2,5 disubstituted amino-oksometyloso-arylo-thiadiazole derivatives.
Lukaszuk C; Krajewska-Kułak E; Niewiadomy A; Stachowicz J; Głaszcz U; Oksiejczuk E
Adv Med Sci; 2007; 52 Suppl 1():26-9. PubMed ID: 18229628
[TBL] [Abstract][Full Text] [Related]
26. Lovastatin protects mesenchymal stem cells against hypoxia- and serum deprivation-induced apoptosis by activation of PI3K/Akt and ERK1/2.
Xu R; Chen J; Cong X; Hu S; Chen X
J Cell Biochem; 2008 Jan; 103(1):256-69. PubMed ID: 17497701
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of hyphae formation and SIR2 expression in Candida albicans treated with fresh Allium sativum (garlic) extract.
Low CF; Chong PP; Yong PV; Lim CS; Ahmad Z; Othman F
J Appl Microbiol; 2008 Dec; 105(6):2169-77. PubMed ID: 19120662
[TBL] [Abstract][Full Text] [Related]
28. Mycological and electron microscopic study of Solanum chrysotrichum saponin SC-2 antifungal activity on Candida species of medical significance.
Herrera-Arellano A; Martínez-Rivera Mde L; Hernández-Cruz M; López-Villegas EO; Rodríguez-Tovar AV; Alvarez L; Marquina-Bahena S; Navarro-García VM; Tortoriello J
Planta Med; 2007 Dec; 73(15):1568-73. PubMed ID: 18058612
[TBL] [Abstract][Full Text] [Related]
29. Vacuolar dynamics during the morphogenetic transition in Candida albicans.
Veses V; Gow NA
FEMS Yeast Res; 2008 Dec; 8(8):1339-48. PubMed ID: 19054134
[TBL] [Abstract][Full Text] [Related]
30. Mechanism of action of coumarin and silver(I)-coumarin complexes against the pathogenic yeast Candida albicans.
Thati B; Noble A; Rowan R; Creaven BS; Walsh M; McCann M; Egan D; Kavanagh K
Toxicol In Vitro; 2007 Aug; 21(5):801-8. PubMed ID: 17350222
[TBL] [Abstract][Full Text] [Related]
31. Antifungal activity of the amyrin derivatives and in vitro inhibition of Candida albicans adhesion to human epithelial cells.
Johann S; Soldi C; Lyon JP; Pizzolatti MG; Resende MA
Lett Appl Microbiol; 2007 Aug; 45(2):148-53. PubMed ID: 17651210
[TBL] [Abstract][Full Text] [Related]
32. Baicalein induces programmed cell death in Candida albicans.
Dai BD; Cao YY; Huang S; Xu YG; Gao PH; Wang Y; Jiang YY
J Microbiol Biotechnol; 2009 Aug; 19(8):803-9. PubMed ID: 19734718
[TBL] [Abstract][Full Text] [Related]
33. Plagiochin E, an antifungal active macrocyclic bis(bibenzyl), induced apoptosis in Candida albicans through a metacaspase-dependent apoptotic pathway.
Wu XZ; Chang WQ; Cheng AX; Sun LM; Lou HX
Biochim Biophys Acta; 2010 Apr; 1800(4):439-47. PubMed ID: 20064588
[TBL] [Abstract][Full Text] [Related]
34. Antifungal activity of Morinda citrifolia fruit extract against Candida albicans.
Jainkittivong A; Butsarakamruha T; Langlais RP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):394-8. PubMed ID: 19716507
[TBL] [Abstract][Full Text] [Related]
35. Selective damage to hyphal form through light-induced delivery of nitric oxide to Candida albicans colonies.
Heilman BJ; Tadle AC; Pimentel LR; Mascharak PK
J Inorg Biochem; 2013 Jun; 123():18-22. PubMed ID: 23501134
[TBL] [Abstract][Full Text] [Related]
36. Catalase gene disruptant of the human pathogenic yeast Candida albicans is defective in hyphal growth, and a catalase-specific inhibitor can suppress hyphal growth of wild-type cells.
Nakagawa Y
Microbiol Immunol; 2008 Jan; 52(1):16-24. PubMed ID: 18352908
[TBL] [Abstract][Full Text] [Related]
37. Possible mechanism of antifungal phenazine-1-carboxamide from Pseudomonas sp. against dimorphic fungi Benjaminiella poitrasii and human pathogen Candida albicans.
Tupe SG; Kulkarni RR; Shirazi F; Sant DG; Joshi SP; Deshpande MV
J Appl Microbiol; 2015 Jan; 118(1):39-48. PubMed ID: 25348290
[TBL] [Abstract][Full Text] [Related]
38. Honey flavonoids inhibit Candida albicans morphogenesis by affecting DNA behavior and mitochondrial function.
Canonico B; Candiracci M; Citterio B; Curci R; Squarzoni S; Mazzoni A; Papa S; Piatti E
Future Microbiol; 2014; 9(4):445-56. PubMed ID: 24810344
[TBL] [Abstract][Full Text] [Related]
39. Antifungal effect of high- and low-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-D-glucosamine against Candida albicans, Candida krusei and Candida glabrata.
Seyfarth F; Schliemann S; Elsner P; Hipler UC
Int J Pharm; 2008 Apr; 353(1-2):139-48. PubMed ID: 18164151
[TBL] [Abstract][Full Text] [Related]
40. A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole.
Lignell A; Johansson A; Löwdin E; Cars O; Sjölin J
Clin Microbiol Infect; 2007 Jun; 13(6):613-9. PubMed ID: 17378925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
